Prediction of COVID Criticality Score with Laboratory, Clinical and CT Images using Hybrid Regression Models

Abstract

Background and Objective: Rapid and precise diagnosis of COVID-19 is very critical in hotspot regions. The main aim of this proposed work is to investigate the baseline, laboratory and CT features of COVID-19 affected patients of two groups (Early and Critical stages). The detection model for COVID-19 is built depending upon the manifestations that define the severity of the disease. Methods: The CT scan images are fed into the various deep learning, machine learning and hybrid learning models to mine the necessary features and predict CT Score. The predicted CT score along with other clinical, laboratory and CT scan image features are then passed to train the various Regression models for predicting the COVID Criticality (CC) Score. These baseline, laboratory and CT features of COVID-19 are reduced using Statistical analysis and Univariate logistic regression analysis. Results: When analysing the prediction of CT scores using images alone, AlexNet+Lasso yields better outcome with regression score of 0.9643 and RMSE of 0.0023 when compared with Decision tree (RMSE of 0.0034; Regression score of 0.9578) and GRU (RMSE of 0.1253; regression score of 0.9323). When analysing the prediction of CC scores using CT scores and other baseline, laboratory and CT features, VGG-16+Linear Regression yields better results with regression score of 0.9911 and RMSE of 0.0002 when compared with Linear SVR (RMSE of 0.0006; Regression score of 0.9911) and LSTM (RMSE of 0.0005; Regression score of 0.9877). The correlation analysis is performed to identify the significance of utilizing other features in prediction of CC Score. The correlation coefficient of CT scores with actual value is 0.93 and 0.92 for Early stage group and Critical stage group respectively. The correlation coefficient of CC scores with actual value is 0.96 for Early stage group and 0.95 for Critical stage group.The classification of COVID-19 patients are carried out with the help of predicted CC Scores. Conclusions: This proposed work is carried out in the motive of helping radiologists in faster categorization of COVID patients as Early or Severe staged using CC Scores. The automated prediction of COVID Criticality Score using our diagnostic model can help radiologists and physicians save time for carrying out further treatment and procedures.

A privacy-aware method for COVID-19 detection in chest CT images using lightweight deep conventional neural network and blockchain

“… TL? Scarpiniti, Sarv Ahrabi [ 68 ] A histogram-based 90.1 90.3 90.4 91 No No Perumal, Narayanan [ 69 ] CNN 92.3 91.5 92.6 93 No No Uemura, Näppi [ 70 ] GAN 95.1 95.4 96 95.3 No No Zhao, Xu [ 71 ] 3D V-Net 97.4 97.7 97.2 98.7 No No Hu, Huang [ 72 ] DNN 97.2 97.1 98.2 99 No No Toğaçar, Muzoğlu [ 73 ] CNN 97.6 97.3 98.1 99.1 No No Castiglione, Vijayakumar [ 74 ] ADECO-CNN 98.2 98.6 98.4 99 No Yes …”

Exploring and validating the prognostic value of pathomics signatures and genomics in patients with cutaneous melanoma based on bioinformatics and deep learning

“…[23][24][25] A number of studies have also predicted the prognosis of patients based on laboratory indicators and clinical traits through clinical prediction models. [26][27][28] As the technology of DL in image processing continues to develop, researchers have started to evaluate pathology images through DL to predict the prognosis of cancer patients. [29][30][31] Pathology images,as the gold standard for cancer diagnosis, are naturally the focus of DL applications in the medical field.…”

Decision trees for early prediction of inadequate immune response to coronavirus infections: a pilot study on COVID-19

“…In fact, it is well-known that patients’ data are difficult to gather, and considering that ML models rely on large datasets, this problem plays an important role on models’ generalization and performance. Secondly, many laboratory parameters included in the studies are collected after the patient has contracted the virus and the disease has already evolved, thereby excluding the option of early and tailored treatment in high-risk individuals ( 22 , 23 ). Another drawback is that the proposed algorithms have not yet reached the level of a human expert.…”